Psychiatric medications are among the most commonly prescribed drugs in the United States. In 2012, 472 million or 11.6% of all US dispensed prescriptions were for psychiatric medications.1 Many of these prescriptions were for clinical indications that have not been approved by the US Food and Drug Administration.2 Yet despite their widespread use, including for conditions for which there is limited evidence of clinical efficacy, little is known about the risks of adverse drug events associated with the major classes of psychiatric medications in community practice.
Olfson M. Surveillance of Adverse Psychiatric Medication Events. JAMA. 2015;313(12):1256-1257. doi:10.1001/jama.2014.15743